Okay, apologies
Serious safety concerns are rare but include: Systemic infections : Immunocompromised individuals, those with central venous catheters, or patients with damaged gut barriers face increased risk of bacteremia or fungemia from probiotic organisms [19] [20] Antibiotic resistance transfer : Some probiotic strains may carry antibiotic resistance genes Metabolic complications : Rare cases of D-lactic acidosis have been reported with high-dose probiotic use [25] Specific populations requiring caution include patients with severe acute pancreatitis (based on the PROPATRIA trial showing increased mortality), short bowel syndrome, immunosuppression (HIV/AIDS, chemotherapy, organ transplant recipients), and critically ill individuals
It's too early to crown a winner, especially since pivotal data from several pharmaceutical companies is slated to come out later this year
The gap between filings and the actual number of affected patients may be even wider
[26] Meanwhile, adequate vitamin D levels are associated with improved muscle function and reduced risk of muscle loss during weight management
Some patients may reach this range within 912+ months depending on BMI, adherence, and medical monitoring